DOCSLIB.ORG

Relationship Between Using Hormonal Contraceptives, Intrauterine Device and Secondary Infertility

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Relationship Between Using Hormonal Contraceptives, Intrauterine Device and Secondary Infertility Med. J. Cairo Univ., VoL 81, No. 1, March: 191-209, 2013 www.medicaljournalofcairouniversity.com Relationship between Using Hormonal Contraceptives, Intrauterine Device and Secondary Infertility ASMAA T. ABD EL-LATIEF, D.N.Sc.1; AHMED R. EL ADAWY, D.N.Sc.2; MANAL F. MOUSTAFA, D.N.Sc.3 and HAMIDA A. ABD EL HAFEZ, D.N.Sc.4 The Departments of Technical Institute of Nursing 1, Obstetrics & Gynecology Medicine2, Faculty of Medicine, Minia University and Obstetrics & Gynecology Nursing3,4, Faculty of Nursing, Assiut University Abstract Conclusion: The fmdings of the study clarified that I.U.D. and hormonal contraceptives can cause menstrual disorders Introduction: Infertility has been defined as failure to and other complications which can affect fertility. conceive after frequent unprotected sexual intercourse for one or two years. Secondary infertility defined as the inability Recommendations: There is a strong need for increasing to conceive despite exposure to pregnancy for one year (2 women awareness about various family planning methods years in some epidemiological studies), Infertility can be and its disadvantages to decide which one has the least side linked to several causes Family planning methods especially effects before using and how to avoid its complications. hormonal contraceptive methods which contain estrogen and Key Words: Infertility — Family planning — Contraceptives — progestin or progestin only such as are safe and reliable way IUD. to prevent pregnancy for most women but some of them are long acting and fertility may not return for up to 18 months Introduction after being stopped. Intrauterine contraceptive devices can increase the risk of STD's, uterine cancer and upper reproduc- REPRODUCTIVE choices include not only the tive tract infection (RTIs) women which results in serious ability to avoid unwanted childbearing but also consequences, such as pelvic inflammatory disease (PID) and adhesions which lead to infertility so in this study the researcher the possibility of bearing wanted child. The pre- tried to identify to what extent the contraceptive methods can vention, diagnosis and treatment of infertility, the affect fertility. inability to bear children-are the fore and essential part of ensuring reproductive choice [ii. Aim of this Study: Was to determine the relationship between using hormonal contraceptives, intrauterine device Infertility has been defmed as failure to conceive and secondary infertility. after frequent unprotected sexual intercourse for Material and Methods: Correlational design was used in one or two years. Secondary infertility defined as this study. Three hundred women were recruited for the study, the inability to conceive despite exposure to preg- they were divided into two groups included 150 women in nancy for one year (2 years in some epidemiological each (group B) suffering from secondary infertility and (divided into 75 women were using I.U.D. before and 75 were using studies), after having not necessarily have a living hormonal contraceptives and 150 group A (women suffering child [2]. Infertility affects approximately 10-15% from secondary infertility and didn't use any contraceptives of couples of reproductive age, it's prevalence has before). Data was collected from obstetric, gynecology and been stable during the last past 50 years, although pediatric university hospital and infertility center in Minia a shift in etiology and in the age of the patient city. It was carried out in the period from October 2011 to October 2012, using structured interviewing sheet which population has occurred. The average prevalence included: Sociodemographic data, complete history taking of infertility estimated to be 5.5%, 9.4% and 19.7% regarding menstruation, obstetrical history, and family plan- respectively at ages 25-29 years, 30-34 years and ning, medical and surgical history. 35-39 years [3]. Female infertility account for 35% Results: The study revealed statistically significant dif- of infertility. The prevalence varies between regions ferences (p<0.05) among groups in most items regarding and countries. Its pattern is different in developed menstrual and obstetrical history and causes of terminating countries than those in developing regions of the the method which are linked to secondary infertility. world. In developed countries, between 8 and 12% of all couples, experience some form of infertility Correspondence to: Dr. Hamida A. Abd El Hafez, during their reproductive lives. In developing The Department of Obstetrics & Gynecology Nursing, countries where the incidence of reproductive tract Faculty of Nursing, Assiut University infection is high, infertility rates are much higher 191 192 Relationship between Using Hormonal Contraceptives which in many instances preventable. Infertility reproductive tract infection (RTIs) in women result affects about 6 1 million people in the United States in serious consequences, such as pelvic inflamma- (U.S.), about 10% of men and women of reproduc- tory disease pelvic inflammatory disease (PID) tive age [41. and adhesions, resulting in infertility [12]. Globally infertility affects about 50 to 80 millio Family planning methods especially hormonal ncouples at some point to their reproductive lives contraceptive methods which include (oral pills, with a variety of biological and behavioral deter- skin patch, injectable Depo-Provera, and a ring minants In developed countries, between 8 and worn in the vagina) can lead to secondary infertility. 12% of all couples experience has some forms of Hormonal methods of birth group Acontain estrogen infertility during their reproductive lives. In devel- and progestin, or progestin only, and are a safe and oping countries where the incidence of reproductive reliable way to prevent pregnancy for most women tract infection is high, infertility rates are much but some of it is long acting and fertility may not higher which in many instances are preventable return for up to 18 months after being stopped [6]. [51. A study that was done in Kafer Elsheikh in Egypt to assess the prevalence of infertility in rural areas For millions of couples around the world, the it showed that; 7.9% of women reported secondary inability to have children is a personal tragedy. infertility and 2.5% experienced primary infertility, The accompaniment of personal, interpersonal, the prevalence of primary infertility is higher social, and religious expectations brings a sense among women under 30 years than older ages, and of failure, loss, and exclusion to those who are secondary infertility increases with advance in age. infertile [6]. Both types of infertility were higher among women Infertility has increased as a problem over the married under the age of 16 or above 30 years [13]. last 30 years all over the world, regarding to social phenomena, such as the tendency for marriage at Significance of the study: a later age and child bearing, increasing use of Worldwide more than 70 million couples suffer contraception specially Intra Uterine Device (IUD) from infertility, the majority being residents of and abortion. It is a significant public health prob- developing countries. Infertility represents a na- lem with serious social consequences [7]. tional health problem in Africa, affecting10-32% of couples on average Men and women are affected Infertility represents a national health problem by infertility in different ways. Most couples ex- in Africa, affecting 10-32% of couples on average perience the struggle in much the same way. This [8]. Low rates of primary (4,3%) and high rates of is related to the traditional ways men and women secondary infertility (5-23%) could be attributed have been trained to think, feel and act. That men to higher rates of STI-induced infertility [9]. and women can help each other balance thinking The impact of infertility varies in different and feeling as they struggle side by side on their cultures. In communities that are more primitive, journey toward parenthood [14]. the concern about infertile marriage is intense. Egypt is considered one of the developing world Infertility in these communities is taken as displea- in which the prevalence of secondary infertility is sure and a cause of divorce. In our culture as a also high, experiencing rates between 15 and 20% reason for a second marriage or even rarely for [15].A study was conducted in Assuit University suicide. Infertile individual in Upper Egypt is Hospital about infertility in 2006 and it revealed described as functionless person. For the male, it that (22.2%) of women had secondary infertility is a disgrace and stigma of masculinity he is equated [16].The changes in the demographic pattern over to a female [101. the past 30 years in Egypt (the shifting from the Infertility can be linked to several causes. These first face to the end of the second face of the causes have been discussed in several studies such demographic transition) made the problem of in- as ovarian factors, bilateral tubal obstruction, fertility more urgent [13]. Causes for secondary uterine factors, cervical factors, and hormonal infertility are several; so in this research we try to factors among the most common causes reported identify if hormonal Contraceptives and intrauterine are reproductive tract infections (RTIs) [iii. device can be risk factors for secondary infertility. Intrauterine contraceptive devices (IUDs) are Aim of the study: widely used all over the world. IUD use can in- Was to assess the relationship between using crease the risk of sexual
Load more

Recommended publications
  • University of Groningen the Pill and Thrombosis Van Vlijmen, Elizabeth
    University of Groningen The pill and thrombosis van Vlijmen, Elizabeth Femma Willemien IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2016 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): van Vlijmen, E. F. W. (2016). The pill and thrombosis. Rijksuniversiteit Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 08-10-2021 Financial support for the printing of this thesis was kindly provided by the Dutch Medicines Evaluation Board and UMCG/GUIDE.
    [Show full text]
  • Schwerpunkt 40 Jahre Pille
    Familienplanungs- RUNDBRIEF Ausgabe Juni 2000 Nr. 1/2 Inhalt Einleitung 3 Hormonelle Kontrazeption: 40 Jahre Pille 4 – Entwicklungen, die zur Herstellung der Pille führten 4 – Weiterentwicklung der Pille von 1960 bis heute 8 – Die gesellschaftspolitische Bedeutung der Pille 12 – Hormonelle Kontrazeptiva heute in Deutschland 14 – Anwendung der hormonalen Kontrazeptiva nach dem heutigen 17 Wissensstand – Wechselwirkungen 24 Anhang (Ende des Dokuments) – Medikamente, die die Sicherheit A1 der Pille beeinträchtigen können – Liste hormonaler Kontrazeptiva A2 IPPF Informationen – Gestagen-Implantate 27 Forum – Vorgeburtliche Untersuchungen: 28 Möglichkeiten und Grenzen Veranstaltungskalender 29 Stichwortverzeichnis 1999 31 Deutsche Gesellschaft für Familienplanung, Sexualpädagogik und Sexualberatung e.V., Bundesverband e.V., Sexualberatung und Sexualpädagogik für Familienplanung, Gesellschaft Deutsche Stresemannallee 3, 60596 Frankfurt am Main, Telefon 069/639002 Impressum: 2000 Herausgeber: PRO FAMILIA-Bundesverband Redaktion: Dr. med. Ruth Eichmann, Frankfurt am Main Dr. med. Ines Thonke, Frankfurt am Main Dr. med. Jutta Walter, Heidelberg Anschrift: PRO FAMILIA-Bundesverband Stresemannallee 3 60596 Frankfurt am Main Gefördert von der Bundeszentrale für gesundheitliche Aufklärung (BZgA). Familienplanungs- RUNDBRIEF Juni 2000 Nr. 1/2 3 In der Rubrik „HINWEISE“ wird wie üblich in dem Einleitung jeweiligen Familienplanungs-Rundbrief Aktuelles aus der Medizin zu finden sein, das von besonde- rer Bedeutung für die Beratungspraxis ist. Lite- raturneuerscheinungen und Ankündigungen von Veranstaltungen runden die einzelnen Familien- planungs-Rundbriefe ab. In Übereinstimmung mit der gewohnten Gliede- rung befasst sich der erste Familienplanungs- Beibehalten wird ferner der Abschnitt, in welchem Rundbrief des Jahres mit einer Vorschau auf die aktuelle Informationen der IPPF (International im laufenden Jahr geplanten Schwerpunktthe- Planned Parenthood Federation) aufgenommen men. Dafür vorgesehen sind: werden, soweit sie medizinischen Inhalts sind.
    [Show full text]
  • Cleaning up After Sex: an Environmental History of Contraceptives in the United States, 1873—2010 Sarah Ruth Payne
    University of New Mexico UNM Digital Repository History ETDs Electronic Theses and Dissertations 9-3-2010 Cleaning Up After Sex: An Environmental History of Contraceptives in the United States, 1873—2010 Sarah Ruth Payne Follow this and additional works at: https://digitalrepository.unm.edu/hist_etds Recommended Citation Payne, Sarah Ruth. "Cleaning Up After Sex: An Environmental History of Contraceptives in the United States, 1873—2010." (2010). https://digitalrepository.unm.edu/hist_etds/62 This Dissertation is brought to you for free and open access by the Electronic Theses and Dissertations at UNM Digital Repository. It has been accepted for inclusion in History ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact [email protected]. CLEANING UP AFTER SEX: AN ENVIRONMENTAL HISTORY OF CONTRACEPTIVES IN THE UNITED STATES, 1873–2010 BY SARAH R. PAYNE B.A., History, Nebraska Wesleyan University, 1997 M.A., History, University of Wyoming, 2001 DISSERTATION Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy History The University of New Mexico Albuquerque, New Mexico August, 2010 ACKNOWLEDGMENTS My heartfelt thanks go first and foremost to Dr. Virginia Scharff. For her encouragement, insight, and patience, with the dissertation and with life in general, I am truly grateful. Dr. Scharff’s skills as a researcher and writer are matched by her skills as a mentor, which have made possible the quality work of so many of her graduate students. I also thank Dr. Scharff and her Center for the Southwest for providing me funding and experience organizing lectures and workshops, and allowing me to work with so many wonderful scholars.
    [Show full text]
  • Hormones and the Female Voice: an Exploration of the Female Hormonal Cycle from Puberty to Menopause and How It Affects the Vocal Apparatus
    HORMONES AND THE FEMALE VOICE: AN EXPLORATION OF THE FEMALE HORMONAL CYCLE FROM PUBERTY TO MENOPAUSE AND HOW IT AFFECTS THE VOCAL APPARATUS A Dissertation Submitted to the Temple University Graduate Board In Partial Fulfillment of the Requirements for the Degree DOCTOR OF MUSICAL ARTS by Patricia Vigil July 2015 Examining Committee Members: Dr. Christine Anderson, Advisory Chair, Department of Voice and Opera Dr. Rollo Dilworth, Department of Music Education and Therapy Dr. Lawrence Indik, Department of Voice and Opera Dr. Joyce Lindorff, Department of Keyboard Studies © Copyright 2015 by Patricia Vigil All Rights Reserved ABSTRACT The purpose of this paper is to examine the female hormonal cycle throughout a woman’s life and its effects on the singing voice. Dealing with vocal issues brought on by hormonal fluctuations can be extremely frustrating for the professional singer, as these issues can wreak havoc on performance and practice schedules. The best weapon of defense against its unpredictability is information. Unfortunately, data on the female hormonal cycle and its effects on the voice is not covered in most standard vocal pedagogy books. Information on the subject is often relegated to a small section of a chapter, and even then usually describes only the symptoms: edema, hoarseness, and loss of high notes and power. The question as to why these symptoms happen every month and during menopause, and whether there is anything that can be done to alleviate them, remains largely unanswered. A candid discourse on the subject of hormones and the female voice has begun, but now must brought into the open.
    [Show full text]
  • An Archaeology of Sex Hormones
    Beyond the natural body Beyond the Natural Body presents an episode in the history of life sciences that is essential to our current understanding of sex and the body, and the relations between gender and science. Since the early decades of the twentieth century, the notion of the hormonally constructed body has become the dominant mode of conceptualizing bodies, particularly female bodies, to such an extent that we now assume that it is a natural phenomenon. This book challenges the idea that there is such a thing as a “natural” body and demonstrates that it is the process by which scientific claims achieve universal status that constructs such discourses as natural facts. Beyond the Natural Body tells the fascinating story of scientists’ search for the many tons of ovaries, testes and urine that were required in experiments to develop the hormonal body concept. It traces the origins of sex hormones and follows their development through mass-production as drugs to their eventual transformation into the contraceptive pill. Nelly Oudshoorn argues that the power to control sex and the body is not restricted to the domain of texts and ideologies. In addition, she describes the dynamic, capillary action of a science which linked cultural assumptions, concepts, ovaries, urine, diagnostic tests, laboratory equipment, marketing strategies, clinical trials, population policies and bodies, thus transforming the world we live in. Nelly Oudshoorn is Assistant Professor in the Department of Science Dynamics at the University of Amsterdam, and has written numerous articles on gender and biology. Beyond the natural body An archeology of sex hormones Nelly Oudshoorn London and New York First published 1994 by Routledge 11 New Fetter Lane, London EC4P 4EE This edition published in the Taylor & Francis e-Library, 2005.
    [Show full text]
  • “Conceiving” the Pill the 45Th Birthday of the Oral Contraceptive Pill in Europe
    Review Article “Conceiving” the pill The 45th birthday of the oral contraceptive pill in Europe Jean Calleja-Agius, Mark Brincat Abstract In 1931, Ludwig Haberlandt, Professor of Physiology In 1961, the first combined oral contraceptive pill was in Innsbruck, Austria wrote: ‘of all the methods available, introduced in Europe. This pill contained ethinylestradiol hormonal sterilisation, based on a biological principle, if it (0.05mg) and northisterone (4mg). Nowadays, monophasic pill can be applied unobjectively in the human, is the ideal method preparations contain a low dose (20–35 μg) of ethinylestradiol for practical medicine and its future task of birth control.’ His in combination with a progestogen. Progestogens include experiments involved transplanting ovaries from pregnant norethisterone and levonorgestrel (second generation); rabbits under the skin of fertile adult does, and he found that desogestrel and gestodene (third generation); and the they become infertile. newest progestogen, drospirenone (fourth generation). The three most well-known persons who are considered the Risks of the combined oral contraceptive pill include venous pioneers in the development of the oral contraceptive pill are thromboembolism and stroke. Benefits, such as protection Margaret Sanger, Katherine Dexter McCormick and Gregory from ovarian and endometrial cancer, apart from contraception, Goodwin Pincus. They had met in 1951 to initiate the project outweigh the risks if contraindications are observed, and low that resulted in marketing the first oral contraceptive. Margaret dose formulations used. Sanger was a nurse specialising in obstetric care, who introduced the term ‘birth control’ in 1914 in America through a monthly magazine entitled ‘The Woman Rebel’, which she edited. In 1950, Katherine Dexter McCormick, a philanthropist, sent a letter to Sanger indicating her interest in supporting ‘further contraceptive research.’ Both women had long been aware of the pressing social and population problems caused by the lack of adequate birth control.
    [Show full text]
  • Combined Estrogen–Progestogen Contraceptives
    COMBINED ESTROGEN–PROGESTOGEN CONTRACEPTIVES These substances were considered by a previous Working Group, in June 1998 (IARC, 1999), under the title ‘Oral contraceptives, combined’. Since that time, new data have become available, and these have been incorporated into the monograph and taken into consideration in the present evaluation. 1. Exposure Data 1.1 Introduction Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm and reduces the receptivity of the endometrium to implantation. These mechanisms render combined hormonal contraceptives very effective in the preven- tion of pregnancy. Annual failure rates vary between 0.02% (two per 10 000 women/year) when full adherence to instructions for use is assumed (Ketting, 1988) and 5% for typical use (Fu et al., 1999). A variety of innovations have been developed since combined hormonal contra- ceptives were first made available in the late 1950s, but not all of these have proved valuable in practice. Changes in drug components, doses used and the temporal sequen- cing of exposure to drugs have incorporated new technologies and responded to suggested risks. While regional variations in use are abundant, the dominant trends have been towards less androgenic progestogens, lower doses of estrogen and progestogen, the near abandonment of hormonal contraceptives with an estrogen-only phase, a proliferation of different product formulations and the continuing development of novel delivery systems. In combined hormonal contraception, ethinylestradiol is the most common estrogen, although other are used occasionally.
    [Show full text]
  • Oral Contraceptives, Combined
    ORAL CONTRACEPTIVES, COMBINED 1. Exposure Combined oral contraceptives consist of the steroid hormone oestrogen in combi- nation with a progestogen, taken primarily to prevent pregnancy. The same hormones can also be used in other forms for contraception. Combined oral contraceptive pills generally refer to pills in which an oestrogen and a progestogen are given concurrently in a monthly cycle. In contrast, a cycle of sequential oral contraceptive pills includes oestrogen-only pills followed by five to seven days of oestrogen plus progestogen pills. Sequential oral contraceptive pills were removed from the consumer market in the late 1970s; they are covered in an IARC monograph (IARC, 1979, 1987). Combined oral contraceptives are thus usually administered as a pill containing oestrogen and progestogen, which is taken daily for 20–22 days, followed by a seven-day pill-free interval (or seven days of placebo), during which time a withdrawal bleed is expected to occur. The most commonly used oestrogen is ethinyloestradiol, although mestranol is used in some formulations. The pro- gestogens most commonly used in combined oral contraceptives are derived from 19-nor- testosterone and include norethisterone, norgestrel and levonorgestrel, although many others are available (Kleinman, 1990) (see Annex 2, Table 1). Chemical and physical data and information on the synthesis, production, use and regulations and guidelines for hormones used in combined oral contraceptives are given in Annex 1. Annex 2 (Table 1) lists the trade names of many contemporary combined oral contraceptives with their formulations. Combined oral contraceptives are currently available in monophasic, biphasic and triphasic preparations, the terms referring to the number of different doses of progestogen they contain.
    [Show full text]
  • ORAL CONTRACEPTIVES, COMBINED 1. Exposure
    ORAL CONTRACEPTIVES, COMBINED 1. Exposure Combined oral contraceptives consist of the steroid hormone oestrogen in combi- nation with a progestogen, taken primarily to prevent pregnancy. The same hormones can also be used in other forms for contraception. Combined oral contraceptive pills generally refer to pills in which an oestrogen and a progestogen are given concurrently in a monthly cycle. In contrast, a cycle of sequential oral contraceptive pills includes oestrogen-only pills followed by five to seven days of oestrogen plus progestogen pills. Sequential oral contraceptive pills were removed from the consumer market in the late 1970s; they are covered in an IARC monograph (IARC, 1979, 1987). Combined oral contraceptives are thus usually administered as a pill containing oestrogen and progestogen, which is taken daily for 20–22 days, followed by a seven-day pill-free interval (or seven days of placebo), during which time a withdrawal bleed is expected to occur. The most commonly used oestrogen is ethinyloestradiol, although mestranol is used in some formulations. The pro- gestogens most commonly used in combined oral contraceptives are derived from 19-nor- testosterone and include norethisterone, norgestrel and levonorgestrel, although many others are available (Kleinman, 1990) (see Annex 2, Table 1). Chemical and physical data and information on the synthesis, production, use and regulations and guidelines for hormones used in combined oral contraceptives are given in Annex 1. Annex 2 (Table 1) lists the trade names of many contemporary combined oral contraceptives with their formulations. Combined oral contraceptives are currently available in monophasic, biphasic and triphasic preparations, the terms referring to the number of different doses of progestogen they contain.
    [Show full text]
  • Laughing Gas, Viagra, and Lipitor
    Laughing Gas, Viagra, and Lipitor The Human Stories Behind the Drugs We Use Jie Jack Li 1 2006 3 Oxford University Press, Inc., publishes works that further Oxford University’s objective of excellence in research, scholarship, and education. Oxford New York Auckland Cape Town Dar es Salaam Hong Kong Karachi Kuala Lumpur Madrid Melbourne Mexico City Nairobi New Delhi Shanghai Taipei Toronto With offices in Argentina Austria Brazil Chile Czech Republic France Greece Guatemala Hungary Italy Japan Poland Portugal Singapore South Korea Switzerland Thailand Turkey Ukraine Vietnam Copyright © 2006 by Oxford University Press Published by Oxford University Press, Inc. 198 Madison Avenue, New York, New York 10016 www.oup.com Oxford is a registered trademark of Oxford University Press All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of Oxford University Press. Library of Congress Cataloging-in-Publication Data Li, Jie Jack. Laughing gas, viagra, and lipitor : the human stories behind the drugs we use / Jie Jack Li. p. cm. Includes bibliographical references and index. ISBN-13 978-0-19-530099-4 ISBN 0-19-530099-8 1. Drugs—Miscellanea. 2. Nitrous oxide. 3. Sildenafil. I. Title. RM301.15.L5 2006 362.29'9—dc22 2006002586 987654321 Printed in the United States of America on acid-free paper foreword ny person interested in understanding the history of medical A progress and the way in which many of the most important medi- cines came into existence will be well rewarded by reading this latest book by Jie Jack Li, one of the most prolific and interesting authors in the field of molecular medicine and chemistry.
    [Show full text]
  • University of Groningen the Pill and Thrombosis Van Vlijmen, Elizabeth
    University of Groningen The pill and thrombosis van Vlijmen, Elizabeth Femma Willemien IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2016 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): van Vlijmen, E. F. W. (2016). The pill and thrombosis. Rijksuniversiteit Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 23-09-2021 Chapter1 General introduction and outline of thesis Introduction Chapter 1 Introduction Combined oral contraceptives and venous thromboembolism The combined oral contraceptive, i.e. the ‘Pill’, was the first medicinal product developed that had to be taken every day on a regular basis by persons not suffe- ring from any disease. Today, world-wide more than 100 million women start the day with taking the ‘Pill’.1 Although the Pill is a safe and highly effective contracep- tive method in the vast majority of women, in a small group of women its use is associated with a rare but potentially serious adverse event, i.e.
    [Show full text]
  • Oral Contraceptives - Journey So Far: a Review Kanaka Bhushanam GVVS1 and Sakuntala Devi Gampa2,*
    REVIEW Oral contraceptives - journey so far: A review Kanaka Bhushanam GVVS1 and Sakuntala Devi Gampa2,* 1 2 Gitam Medical Collage, Gandhi Nagar, Rushikonda, Visakhapatnam, Andhra Pradesh, India Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India Abstract since 1970s. As per WHO (1998), over 100 million women are using oral contraceptive pills (OCPs) worldwide, mostlyOral contraceptive in developed is acountries. widely accepted In India and only most 2% effectiveof married method women of offertility reproductive control. ageIts wereuse has using been OCPs growing for fertility control during the period from 1990 to 2001. The history, evolution and development of oral pills till Keywords:date is discussed oral contraception; along with the fertility benefits, control; risks and contraceptive side effects pills of oral contraceptive pills. *Corresponding author: Dr. Sakuntala Devi Gampa, Gitam Introduction Medical Collage, Gandhi Nagar, Rushikonda, Visakhapatnam, [email protected] Once upon a time contraception was a taboo in many countries and practicing or even promoting ReceivedAndhra Pradesh, 28 October India. 2015; Email: Revised 11 December 2015; Accepted 19 December 2015; Published 29 December 2015 contraception was punishable. From that situation oral pills have now reached a stage where they are Citation: most widely accepted method of birth control and Kanakabhushanam GVVS, Gampa SD. Oral1 contraceptives- also became a useful therapeutic modality for many journey so far: A review. J Med Sci Res. 2016; 4(1):35-40. DOI: gynaecological conditions avoiding unnecessary Chttp://dx.doi.org/10.17727/JMSR.2016/4-01opyright: © 2016 Kanakabhushanam GVVS, et al. Published by hysterectomies. Many breakthroughs in the article distributed under the terms of the Creative Commons evolution of birth pills are responsible for today’s AttributionKIMS Foundation License, and which Research permits Center.
    [Show full text]